[
  {
    "ts": null,
    "headline": "North America Beta-Glucan Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, EDAP TMS, Johnson & Johnson, Medtronic, Hitachi, Theraclion, Stryker, and GE",
    "summary": "The North America Beta Glucan Market, valued at USD 204.03 million in 2024, is poised to grow to USD 373.85 million by 2033, with a CAGR of 6.96% from 2025 to 2033. This growth is driven by rising consumer demand for immune-boosting and functional food ingredients and increased awareness of beta glucan's health benefits. Beta glucan—a soluble fiber found in grains, fungi, and yeast—offers cholesterol-reducing and immune-modulating properties, gaining traction in functional foods, nutraceuticals,",
    "url": "https://finnhub.io/api/news?id=9a695f3816acc6952f8e0f678e70f27b0d26658dc6967d150502d81d85dce021",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751617140,
      "headline": "North America Beta-Glucan Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, EDAP TMS, Johnson & Johnson, Medtronic, Hitachi, Theraclion, Stryker, and GE",
      "id": 135749159,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "The North America Beta Glucan Market, valued at USD 204.03 million in 2024, is poised to grow to USD 373.85 million by 2033, with a CAGR of 6.96% from 2025 to 2033. This growth is driven by rising consumer demand for immune-boosting and functional food ingredients and increased awareness of beta glucan's health benefits. Beta glucan—a soluble fiber found in grains, fungi, and yeast—offers cholesterol-reducing and immune-modulating properties, gaining traction in functional foods, nutraceuticals,",
      "url": "https://finnhub.io/api/news?id=9a695f3816acc6952f8e0f678e70f27b0d26658dc6967d150502d81d85dce021"
    }
  },
  {
    "ts": null,
    "headline": "Stryker’s Incompass System Secures FDA Nod, Boosting Orthopaedics Innovation Strategy",
    "summary": "Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy. On June 25, Stryker Corporation (NYSE:SYK) announced that its Incompass Total Ankle System, intended for patients with severe rheumatoid, post-traumatic, or degenerative arthritis-related ankle joint damage, received FDA 510(k) clearance. The Incompass system integrates Adaptis Boney Ingrowth Technology and revised instrumentation to facilitate long-term […]",
    "url": "https://finnhub.io/api/news?id=271909ff6b209033a25a346770db79f01bb822aed4202fc394334896d6cf4a1f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751613781,
      "headline": "Stryker’s Incompass System Secures FDA Nod, Boosting Orthopaedics Innovation Strategy",
      "id": 135758484,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy. On June 25, Stryker Corporation (NYSE:SYK) announced that its Incompass Total Ankle System, intended for patients with severe rheumatoid, post-traumatic, or degenerative arthritis-related ankle joint damage, received FDA 510(k) clearance. The Incompass system integrates Adaptis Boney Ingrowth Technology and revised instrumentation to facilitate long-term […]",
      "url": "https://finnhub.io/api/news?id=271909ff6b209033a25a346770db79f01bb822aed4202fc394334896d6cf4a1f"
    }
  }
]